The startup develops peptide therapeutics using advanced synthetic methods to enhance the efficiency of peptide medicine production. By innovating manufacturing technology, the company enables pharmaceutical partners to access high-quality, cost-effective peptide-based treatments more rapidly.
Funding
Funding not disclosed
Founders
Product
Problem
The production of peptide and oligonucleotide therapeutics often faces challenges related to efficiency, cost, and scalability, hindering the accessibility of these advanced medicines. Traditional manufacturing methods can be time-consuming, resource-intensive, and may not consistently yield high-quality products.
Solution
PeptiStar is a contract development and manufacturing organization (CDMO) specializing in peptide and oligonucleotide active pharmaceutical ingredients (APIs). The company addresses the challenges of traditional manufacturing through innovative synthetic methods, advanced equipment, and a comprehensive quality assurance system. PeptiStar offers a suite of services encompassing process development, scale-up, GMP manufacturing, analytical testing, and regulatory support, facilitating a streamlined path from research to commercialization. Their technology portfolio includes microwave-assisted solid-phase synthesis, continuous chromatography purification, and specialized lyophilization techniques, enabling efficient production of complex molecules at various scales.
Target Audience
PeptiStar's primary clients are pharmaceutical and biotechnology companies engaged in the development and commercialization of peptide and oligonucleotide therapeutics.
Features
- Peptide and oligonucleotide synthesis from milligram to multi-kilogram scale
- cGMP-compliant manufacturing for clinical trial and commercial supply
- Proprietary technologies including STag-PS, SYNCSOL, and microwave solid-phase synthesis for enhanced yield and purity
- Continuous chromatography purification for high-resolution separation and impurity removal
- State-of-the-art analytical capabilities for comprehensive product characterization
- Lyophilization process development and optimization for enhanced product stability
- Support for CMC (Chemistry, Manufacturing, and Controls) documentation and regulatory submissions
- Manufacturing in Class 100,000 cleanrooms to ensure product quality and sterility